Last reviewed · How we verify

NCT03627689

Molekule for Allergic Rhinitis/Asthma

Terminated NA Last updated 5 February 2019
What this trial tests

NA trial testing Active air purifier in respiratory allergies/asthma in Asthma in 49 participants. Terminated before completion.

Timeline
13 July 2018
Primary endpoint
31 January 2019
31 January 2019

Quick facts

Lead sponsorMolekule
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment49
Start date13 July 2018
Primary completion31 January 2019
Estimated completion31 January 2019
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Molekule

Who can join

Adults 18 to 65, any sex, with Asthma or Allergic Rhinitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Exposure to airborne allergens and pollutants is linked to symptom severity of allergies, asthma and other respiratory problems. In this study an air purifier using photo-electrochemical oxidation technology (PECO) will be used in the home environment of study participants. The investigator will assess the reduction of symptoms from allergic rhinitis/conjunctivitis and asthma.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Asthma

Currently open trials in the same condition.

Other Molekule trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03627689.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing